CA2014521A1 - N,n'-ditrimethoxybenzoyl piperazines substituees en position 2, procede de preparation et composes therapeutiques les contenant - Google Patents

N,n'-ditrimethoxybenzoyl piperazines substituees en position 2, procede de preparation et composes therapeutiques les contenant

Info

Publication number
CA2014521A1
CA2014521A1 CA2014521A CA2014521A CA2014521A1 CA 2014521 A1 CA2014521 A1 CA 2014521A1 CA 2014521 A CA2014521 A CA 2014521A CA 2014521 A CA2014521 A CA 2014521A CA 2014521 A1 CA2014521 A1 CA 2014521A1
Authority
CA
Canada
Prior art keywords
preparation process
compositions containing
therapeutic compositions
carbon atoms
ditrimethoxybenzoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2014521A
Other languages
English (en)
Other versions
CA2014521C (fr
Inventor
Pierre Braquet
Jean-Jacques Godfroid
Eduardo Pirotzky
Francoise Heymans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of CA2014521A1 publication Critical patent/CA2014521A1/fr
Application granted granted Critical
Publication of CA2014521C publication Critical patent/CA2014521C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002014521A 1989-04-15 1990-04-12 N,n'-ditrimethoxybenzoyl piperazines substituees en position 2, procede de preparation et composes therapeutiques les contenant Expired - Fee Related CA2014521C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8908587.2 1989-04-15
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines

Publications (2)

Publication Number Publication Date
CA2014521A1 true CA2014521A1 (fr) 1990-10-15
CA2014521C CA2014521C (fr) 1997-09-09

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002014521A Expired - Fee Related CA2014521C (fr) 1989-04-15 1990-04-12 N,n'-ditrimethoxybenzoyl piperazines substituees en position 2, procede de preparation et composes therapeutiques les contenant

Country Status (32)

Country Link
US (1) US5019576A (fr)
JP (1) JP2633709B2 (fr)
KR (1) KR900016178A (fr)
AR (1) AR247736A1 (fr)
AT (1) AT399337B (fr)
AU (1) AU631334B2 (fr)
BE (1) BE1007245A3 (fr)
CA (1) CA2014521C (fr)
CH (1) CH681301A5 (fr)
DE (1) DE4011925A1 (fr)
DK (1) DK91890A (fr)
DZ (1) DZ1407A1 (fr)
ES (1) ES2019554A6 (fr)
FI (1) FI92058C (fr)
FR (2) FR2645859B1 (fr)
GB (2) GB8908587D0 (fr)
GR (1) GR1000355B (fr)
HK (1) HK95092A (fr)
IE (1) IE65058B1 (fr)
IN (1) IN175799B (fr)
IT (1) IT1241631B (fr)
LU (1) LU87719A1 (fr)
MA (1) MA21805A1 (fr)
NL (1) NL9000798A (fr)
NO (1) NO176098C (fr)
NZ (1) NZ233250A (fr)
OA (1) OA09446A (fr)
PT (1) PT93736B (fr)
SE (1) SE505186C2 (fr)
SG (1) SG92092G (fr)
TN (1) TNSN90051A1 (fr)
ZA (1) ZA902566B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
NZ307716A (en) * 1995-05-02 1999-10-28 Schering Corp 4-[3,5-bis(trifluoromethyl)phenyl]-2-(3,4-dichlorophenyl)-1-[[( substituted heterocyclic)amino]acetyl] piperazine derivatives and medicaments
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
EP0318235A3 (fr) * 1987-11-25 1991-05-02 Takeda Chemical Industries, Ltd. Composés de pipérazine PAF-antagoniste 1,4-disubstitués et leur production
TW199890B (fr) * 1988-05-23 1993-02-11 Glaxo Group Ltd
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
SE9001269L (sv) 1990-10-16
GR1000355B (el) 1992-06-25
IN175799B (fr) 1995-08-26
NO901631D0 (no) 1990-04-10
OA09446A (fr) 1992-10-15
AR247736A1 (es) 1995-03-31
GB2230262A (en) 1990-10-17
MA21805A1 (fr) 1990-12-31
SG92092G (en) 1992-12-04
JP2633709B2 (ja) 1997-07-23
LU87719A1 (fr) 1990-07-24
GB2230262B (en) 1992-02-26
NO176098C (no) 1995-02-01
NZ233250A (en) 1991-03-26
FI92058B (fi) 1994-06-15
FR2645743A1 (fr) 1990-10-19
ES2019554A6 (es) 1991-06-16
DK91890A (da) 1990-10-16
IT9020020A1 (it) 1991-10-12
SE9001269D0 (sv) 1990-04-06
FR2645743B1 (fr) 1992-06-05
FI901883A0 (fi) 1990-04-12
NL9000798A (nl) 1990-11-01
AU631334B2 (en) 1992-11-19
GB9007612D0 (en) 1990-05-30
SE505186C2 (sv) 1997-07-14
JPH02292266A (ja) 1990-12-03
AT399337B (de) 1995-04-25
GB8908587D0 (en) 1989-06-01
IT1241631B (it) 1994-01-25
IT9020020A0 (it) 1990-04-12
FR2645859A1 (fr) 1990-10-19
NO176098B (no) 1994-10-24
IE901314L (en) 1990-10-15
DZ1407A1 (fr) 2004-09-13
TNSN90051A1 (fr) 1991-03-05
DK91890D0 (da) 1990-04-11
KR900016178A (ko) 1990-11-12
FR2645859B1 (fr) 1992-06-05
CH681301A5 (fr) 1993-02-26
AU5326190A (en) 1990-11-01
ATA86690A (de) 1994-09-15
BE1007245A3 (fr) 1995-05-02
PT93736B (pt) 1996-09-30
PT93736A (pt) 1990-11-20
US5019576A (en) 1991-05-28
NO901631L (no) 1990-10-16
GR900100270A (en) 1991-09-27
CA2014521C (fr) 1997-09-09
FI92058C (fi) 1994-09-26
DE4011925A1 (de) 1990-10-18
IE65058B1 (en) 1995-10-04
HK95092A (en) 1992-12-04
ZA902566B (en) 1991-01-30

Similar Documents

Publication Publication Date Title
GB8711802D0 (en) Dithioacetal compounds
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
MX9306831A (es) Nuevos compuestos heterociclicos.
ATE57919T1 (de) Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide.
CA2014521A1 (fr) N,n'-ditrimethoxybenzoyl piperazines substituees en position 2, procede de preparation et composes therapeutiques les contenant
DE69623497D1 (de) 1-methylcarbapenem-derivate
ES2046641T3 (es) Composicion antitumoral.
EP0785190A3 (fr)
DK0420224T3 (da) Anthihepatopatisk middel
SE8903312D0 (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
MY100957A (en) Quinazolinone compounds and processes for the preparation thereof.
ES2018404A6 (es) Procedimiento para preparar nuevas 2-metoxicarbonil sustituido-n, n'-di-(trimetoxibenzoil)-piperazinas.
MY101628A (en) Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them.
GB2190587B (en) Prophylactic and curing composition for arteriosclerosis
ES8707194A1 (es) Un metodo para producir derivados de trihaloimidazol
EP0273357A3 (en) Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed